// OVERVIEW
Novo Nordisk is a Danish pharmaceutical company best known for GLP-1 drugs including Ozempic and Wegovy.
Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
mention·Sourcery·OCTOBER 14, 2026
Source→02
mention·Lightcone·MAY 25, 2026
“If you fast forward 20 years, this intervention caused Novo Nordisk to have for a time a market valuation greater than the GDP of Denmark.”
Source→03
funding·PitchBook News·MAY 4, 2026
“Hemab Therapeutics raised $301.5M in US IPO; backed by RA Capital and Novo Nordisk.”
Source→04
funding·PitchBook News·MAY 1, 2026
“Avalyn — Raised $300M in US IPO; backed by SR One and Novo Nordisk”
Source→05
mention·PitchBook News·APRIL 21, 2026
“For Novo Nordisk, GLP-1 products including Ozempic and Wegovy accounted for approximately 75% of its total revenue.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.